AbbVie will participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference on Nov. 29, the company said in a press release.
Bill Chase, AbbVie executive vice president and chief financial officer, will give a presentation at 7 a.m. CST. A live webcast of the session will be available, and an archived version will be posted online later in the day, the release said.
AbbVie is a research-driven company in the biopharmaceutical industry that continues to investigate innovative advanced therapies for complex conditions throughout the world. AbbVie's mission is to leverage its employees' expertise to bring better treatments across the areas of immunology, oncology, virology and neuroscience. AbbVie is in over 75 countries.
